Solórzano Linaldi

The ‘professional and efficient’ Solórzano Linaldi is the the key stand-alone boutique in this market segment and -according to clients- has ’the specialised personnel necessary’ and the ‘ability to adapt both technologically and in terms of human resources to meet the needs of its customers’; it handles the full range of life science matters, particularly as regards health and pharmaceuticals, chemicals, medical devices, cannabis, food and beverages, technology, media and entertainment, telemedicine and e-commerce. The team is led by Guillermo Solórzano, whose life sciences practice combines health regulation, intellectual property, foreign trade, and transactional corporate law; with over 25 years’ experience, he has led on relevant cases of biotech drugs in the market; on the design and implementation of legal strategies to obtain the marketing authorisation of drugs, generic drugs, biotech drugs and biosimilar drugs; and also undertaken successful litigation cases against major pharmaceutical companies. Fellow name-partner Luis López Linaldi’s expertise is primarily in the areas of international dispute settlement, technical barriers to trade, foreign investment, trade in services, and sanitary and phytosanitary measures; he also has particular knowledge of the practicalities and regulatory norms associated with export/import procedures concerning the life sciences sector. Of late the practice has been particularly active with judicial and administrative appeals, the obtaining of licenses and marketing authorisations, and cross border issues – particularly relating to regulatory processes. The firm continues to attract new clients – such as pharma company Novagenic Mexico and e-commerce distributor Riogrande – and recent headline mandates include representing Asofarma against Novartis’ opposition to its application for a sanitary registration, and representing the same client in an administrative infringement proceeding initiated by Wyeth and Pfizer before the Mexican Institute of Industrial Property (IMPI) – the case that is currently before the Supreme Court of Justice of the Nation. The arrival of  counsel Jorge Ortega – a January-2023 hire with extensive experience in the public sector (notably in the Secretaría de Hacienda y Crédito Público, and in the Secretaría de Gobernación) – has notably strengthened the firm’s capabilities in relation to compliance and public procurement matters. At associate level, key support comes from senior Eréndira Frias, who has over 15 years’ experience and primarily advises national and multinational companies on pharmaceutical, sanitary and administrative litigation; fellow senior Christian Parra, principally an IP litigator; and associate Alan Osorio Aragón who advises on market analysis and health regulation and also coordinates the operation of the firm’s “intelligence unit” regarding regulatory norms, globally. The 10-strong legal team can also draw on the input of three chemical engineers. Since publication, the team has been further strengthened with the hire of Mariana Larrea Arias - formerly of Santamarina y Steta - as counsel (effective as of October 2023).